These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2227076)

  • 1. Steatorrhoea in cirrhosis: effect of ursodeoxycholic acid administration.
    Salvioli G; Carati L; Lugli R
    J Int Med Res; 1990; 18(4):289-97. PubMed ID: 2227076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy.
    Nakamura K; Yoneda M; Kimura A; Tamori K; Yokohama S; Sato Y; Kato T; Hasegawa T; Saito H; Aoshima M; Fujita M; Makino I
    J Gastroenterol Hepatol; 1996 Apr; 11(4):385-90. PubMed ID: 8713707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
    Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
    Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ursodeoxycholic acid treatment on intestinal absorption of triglycerides in man.
    Einarsson K; Björkhem I; Eklöf R; Ewerth S; Nilsell K; Blomstrand R
    Scand J Gastroenterol; 1984 Mar; 19(2):283-8. PubMed ID: 6719039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
    Lindor KD; Lacerda MA; Jorgensen RA; DeSotel CK; Batta AK; Salen G; Dickson ER; Rossi SS; Hofmann AF
    Am J Gastroenterol; 1998 Sep; 93(9):1498-504. PubMed ID: 9732932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
    Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.
    von Haehling S; Schefold JC; Jankowska EA; Springer J; Vazir A; Kalra PR; Sandek A; Fauler G; Stojakovic T; Trauner M; Ponikowski P; Volk HD; Doehner W; Coats AJ; Poole-Wilson PA; Anker SD
    J Am Coll Cardiol; 2012 Feb; 59(6):585-92. PubMed ID: 22300693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice.
    Pelletier G; Roulot D; Davion T; Masliah C; Causse X; Oberti F; Raabe JJ; Van Lemmens C; Labadie H; Serfaty L;
    Hepatology; 2003 Apr; 37(4):887-92. PubMed ID: 12668982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal triglycerides and fatty acids in the differential diagnosis of pancreatic insufficiency and intestinal malabsorption in patients with low fat intakes.
    Nakamura T; Takebe K; Tando Y; Arai Y; Yamada N; Ishii M; Kikuchi H; Imamura K
    J Int Med Res; 1995; 23(1):48-55. PubMed ID: 7774758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.
    Colombo C; Battezzati PM; Podda M; Bettinardi N; Giunta A
    Hepatology; 1996 Jun; 23(6):1484-90. PubMed ID: 8675168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of ursodeoxycholic acid (UDCA) therapy for compensatory liver cirrhosis on liver function tests and serum bile acid metabolism].
    Nakamura K; Aoshima M; Tani M; Kato T; Fugita M; Kimura A; Hasegawa T; Akiyama K; Makino I
    Nihon Shokakibyo Gakkai Zasshi; 1992 Dec; 89(12):2762-70. PubMed ID: 1491464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of bile acid malabsorption on steatorrhoea and symptoms in patients with chronic diarrhoea.
    Ung KA; Kilander AF; Lindgren A; Abrahamsson H
    Eur J Gastroenterol Hepatol; 2000 May; 12(5):541-7. PubMed ID: 10833098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
    Glantz A; Marschall HU; Lammert F; Mattsson LA
    Hepatology; 2005 Dec; 42(6):1399-405. PubMed ID: 16317669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cisapride on defaecation in normal human subjects--lack of effect on faecal excretion of water, fat, and bile acids.
    Berger V; Armbrecht U; Heusinger A; Wienbeck M; Stockbrügger R
    Aliment Pharmacol Ther; 1989 Dec; 3(6):547-52. PubMed ID: 2518868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Ursodeoxycholic Acid on Small Intestinal Bacterial Overgrowth in Patients with Functional Dyspepsia: A Pilot Randomized Controlled Trial.
    Kim BT; Kim KM; Kim KN
    Nutrients; 2020 May; 12(5):. PubMed ID: 32422942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
    Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis.
    Corpechot C; Carrat F; Bonnand AM; Poupon RE; Poupon R
    Hepatology; 2000 Dec; 32(6):1196-9. PubMed ID: 11093724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic liver disease with ursodeoxycholic acid.
    Guslandi M
    J Int Med Res; 1990; 18(6):497-505. PubMed ID: 2292332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.
    Combes B; Emerson SS; Flye NL; Munoz SJ; Luketic VA; Mayo MJ; McCashland TM; Zetterman RK; Peters MG; Di Bisceglie AM; Benner KG; Kowdley KV; Carithers RL; Rosoff L; Garcia-Tsao G; Boyer JL; Boyer TD; Martinez EJ; Bass NM; Lake JR; Barnes DS; Bonacini M; Lindsay KL; Mills AS; Markin RS; Rubin R; West AB; Wheeler DE; Contos MJ; Hofmann AF
    Hepatology; 2005 Nov; 42(5):1184-93. PubMed ID: 16250039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.